Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis.
This study provides the first systematic evaluation of papillomavirus type and viral mutation occurring during the course of juvenile-onset recurrent respiratory papillomatosis. One hundred ninety-nine consecutive papillomas excised from 47 children between 1981 and 1996 at The New Children's Hospital in Sydney, Australia, were tested for human papillomavirus (HPV) DNA by PCR. PCR products from the viral upstream regulatory region (URR) enhancer were sequenced, and variation was related to clinical variables. Forty-four of the 47 children had HPV-induced papillomas, with type 11 accounting for 24 (55%) and type 6 accounting for 19 (43%); one (2%) was positive for either type 6 or 11. Overall, 183 (98%) of the 186 samples with amplifiable DNA were HPV positive. There was no change in HPV type over time and no statistically significant association between HPV type and disease aggressiveness. One novel, large-scale URR duplication was identified in an HPV type 11 isolate in the last of a series of six papillomas examined and the first from the bronchus. However, the duplication was not found in HPV type 11 isolates from the associated pulmonary carcinoma and its metastases in other organs. Three of 14 URR point mutations coincided with transcription factor binding sites, but there were no obvious associations with clinical course. Chi-square and multiple linear regression analyses of clinicopathological variables revealed early age at diagnosis (less than 4 years) as an independent predictor of aggressive disease (P < 0.001). A bimodal distribution of the age at diagnosis was noted, with peaks at 2 and 11 years of age.
Gabbott
M
M
Department of Infectious Diseases, The University of Sydney, New South Wales, Australia.
Cossart
Y E
YE
Kan
A
A
Konopka
M
M
Chan
R
R
Rose
B R
BR
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005809:Genes, Regulator; D005814:Genes, Viral; D014644:Genetic Variation; D006801:Humans; D007223:Infant; D007822:Laryngeal Neoplasms / Q000209:etiology / Q000821:virology; D008297:Male; D009154:Mutation; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000821:virology; D010212:Papilloma / Q000209:etiology* / Q000821:virology; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000209:etiology* / Q000821:virology; D016133:Polymerase Chain Reaction; D012142:Respiratory Tract Neoplasms / Q000209:etiology* / Q000821:virology; D014412:Tumor Virus Infections / Q000209:etiology* / Q000821:virology